SCHEMBL9569962

SCHEMBL9569962

CCCCCn1c(CC[O])nc2ccccc21

nearest known ligand 0.65

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 5/20 0.65
▸ LMNA P02545 3/20 0.65
▸ SMN1; SMN2 Q16637 2/20 0.65
▸ POLB P06746 1/20 0.62
▸ TLR8 Q9NR97 2/20 0.61
▸ RECQL P46063 1/20 0.60
▸ MAPT P10636 1/20 0.59
▸ HTT P42858 3/20 0.59
▸ GAA P10253 2/20 0.59
▸ ALDH1A1 P00352 1/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9570313 0.99 TP53 (0.63) TP53LMNASMN1; SMN2POLBTLR8
SCHEMBL9570117 0.96 GAA (0.64) TP53LMNASMN1; SMN2POLBTLR8
SCHEMBL2361056 0.90 TP53 (0.69) TP53LMNASMN1; SMN2POLBTLR8
SCHEMBL9570295 0.90 MAPT (0.64) LMNASMN1; SMN2POLBRECQLMAPT
SCHEMBL28716632 0.88 LMNA (0.67) TP53LMNASMN1; SMN2POLBTLR8
SCHEMBL29968953 0.88 LMNA (0.67) TP53LMNASMN1; SMN2POLBTLR8
SCHEMBL28878994 0.88 LMNA (0.67) TP53LMNASMN1; SMN2POLBTLR8
SCHEMBL29968482 0.88 LMNA (0.67) TP53LMNASMN1; SMN2POLBTLR8
SCHEMBL28717937 0.88 LMNA (0.71) TP53LMNASMN1; SMN2POLBTLR8
SCHEMBL28879019 0.88 LMNA (0.67) TP53LMNASMN1; SMN2POLBTLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5270322-A Imidazo[1,2-a]pyridines, pharmaceutical compositions containing these compounds and processes for preparing them DR. KARL THOMAE GMBH (DE) 1993-12-14 — — US disclosed
EP-0555825-A1 Imidazo(1,2-a)pyridines as angiotensin-II-antagonists Dr. Karl Thomae GmbH (DE) 1993-08-18 — — EP disclosed
Send feedback